Pricing Log in Create free account
Friday 6 November 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

JAZZ Healthcare Biotechnology

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024.

Revenue
+10.4%
EPS
−280.5%
Free cash flow
−60.4%
Total debt
+3.88%

Quarter to September 2026, against a year earlier

235.47 8.15 +3.59%
Market cap
$14.6B
P/E
62.6×
Fwd P/E
35.9×
Dividend yield
—
F-score
5/9
Altman Z
1.37
Beneish M
−3.03
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Jazz Pharmaceuticals PLC (JAZZ) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Jazz Pharmaceuticals PLC (JAZZ) trades at a EV/FCF of 26.2×. Over the past ten years it has ranged from 5.9× (May 2025) to 70.9× (March 2015); the current reading is higher than 87% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 42.0× 427.74%
FY2024 8.0× (31.09%)
FY2023 11.6× (38.86%)
FY2022 18.9× 6.02%
FY2021 17.8× 1.28%
FY2020 17.6× 18.91%
FY2019 14.8× 27.55%
FY2018 11.6× (27.18%)
FY2017 15.9× (21.95%)
FY2016 20.4× (3.04%)

Quarterly newest first

Period EV/FCF Change
Sep 2026 26.6× 116.98%
Jun 2026 12.3× (72.86%)
Mar 2026 45.2× 7.59%
Dec 2025 42.0× 360.11%
43 more quarters

Against its own ten years

Low 5.9× High 70.9×
Ten-year median 17.4×
Current reading's percentile 92

EV/FCF against peers

Company EV/FCF
KYMR Kymera Therapeutics, Inc. compare −40.2×
BBIO BridgeBio Pharma, Inc. compare −39.7×
SMMT Summit Therapeutics PLC compare −23.1×
EXEL Exelixis, Inc. compare 14.1×
HALO Halozyme Therapeutics, Inc. compare 18.4×
JAZZ Jazz Pharmaceuticals PLC 26.2×
BMRN BioMarin Pharmaceutical Inc. compare 26.3×
ASND Ascendis Pharma A/S compare 41.1×
TECH Bio-Techne Corp compare 42.9×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on JAZZ